Morgan Stanley’s 9 Meters Biopharma, Inc. Common Stock NMTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,962
| Closed | -$1.99K | – | 7824 |
|
|
2023
Q2 | $1.99K | Buy |
2,962
+380
| +15% | +$255 | ﹤0.01% | 7198 |
|
|
2023
Q1 | $3.59K | Sell |
2,582
-572
| -18% | -$795 | ﹤0.01% | 7133 |
|
|
2022
Q4 | $3.97K | Sell |
3,154
-1,980
| -39% | -$2.5K | ﹤0.01% | 7208 |
|
|
2022
Q3 | $22K | Sell |
5,134
-629
| -11% | -$2.7K | ﹤0.01% | 6762 |
|
|
2022
Q2 | $29K | Buy |
5,763
+826
| +17% | +$4.16K | ﹤0.01% | 6848 |
|
|
2022
Q1 | $60K | Sell |
4,937
-925
| -16% | -$11.2K | ﹤0.01% | 6627 |
|
|
2021
Q4 | $114K | Buy |
5,862
+1,364
| +30% | +$26.5K | ﹤0.01% | 6360 |
|
|
2021
Q3 | $118K | Sell |
4,498
-54,115
| -92% | -$1.42M | ﹤0.01% | 6280 |
|
|
2021
Q2 | $1.29M | Buy |
58,613
+56,097
| +2,230% | +$1.23M | ﹤0.01% | 4933 |
|
|
2021
Q1 | $59K | Buy |
2,516
+2,241
| +815% | +$52.6K | ﹤0.01% | 6283 |
|
|
2020
Q4 | $5K | Buy |
+275
| New | +$5K | ﹤0.01% | 6783 |
|
|
2020
Q2 | – | Sell |
-50
| Closed | -$1K | – | 6785 |
|
|
2020
Q1 | $1K | Hold |
50
| – | – | ﹤0.01% | 6509 |
|
|
2019
Q4 | $1K | Sell |
50
-3,140
| -98% | -$62.8K | ﹤0.01% | 6606 |
|
|
2019
Q3 | $68K | Sell |
3,190
-438
| -12% | -$9.34K | ﹤0.01% | 5582 |
|
|
2019
Q2 | $84K | Buy |
3,628
+136
| +4% | +$3.15K | ﹤0.01% | 5405 |
|
|
2019
Q1 | $135K | Sell |
3,492
-1,476
| -30% | -$57.1K | ﹤0.01% | 5252 |
|
|
2018
Q4 | $229K | Buy |
4,968
+550
| +12% | +$25.4K | ﹤0.01% | 5226 |
|
|
2018
Q3 | $604K | Buy |
4,418
+1,731
| +64% | +$237K | ﹤0.01% | 4887 |
|
|
2018
Q2 | $1.27M | Buy |
2,687
+2,290
| +577% | +$1.08M | ﹤0.01% | 4452 |
|
|
2018
Q1 | $218K | Buy |
+397
| New | +$218K | ﹤0.01% | 5433 |
|